NASDAQ : NKTX
Nkarta, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.56 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 111.73M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 23.56M | 25.41M | 31.45M | 29.58M | 28.06M | 23.02M |
| Research & Development | 99.51M | 90.43M | 96.74M | 96.77M | 90.90M | 63.41M |
| Operating Expenses | 123.08M | 115.84M | 128.19M | 126.35M | 118.95M | 86.43M |
| Operating Income | -123.08M | -115.84M | -128.19M | -126.35M | -118.95M | -86.43M |
| Interest & Investment Income | 12.52M | 15.49M | 19.32M | 14.11M | 5.59M | 370.00K |
| Other Non Operating Income (Expenses) | 2.31M | 2.33M | 87.00K | 8.00K | 20.00K | -16.00K |
| EBT Excluding Unusual Items | -108.24M | -98.02M | -108.79M | -112.23M | -113.35M | -86.08M |
| Merger & Restructuring Charges | -336.00K | -5.37M | -1.20M | |||
| Gain (Loss) on Sale of Investments | 94.00K | 94.00K | 34.00K | -490.00K | ||
| Asset Writedown | -8.84M | -791.00K | -4.10M | |||
| Pretax Income | -117.32M | -104.08M | -108.79M | -117.50M | -113.84M | -86.08M |
| Net Income | -117.32M | -104.08M | -108.79M | -117.50M | -113.84M | -86.08M |
| Net Income to Common | -117.32M | -104.08M | -108.79M | -117.50M | -113.84M | -86.08M |
| Shares Outstanding (Basic) | 74.21M | 73.99M | 67.87M | 49.01M | 43.63M | 32.86M |
| Shares Outstanding (Diluted) | 74.21M | 73.99M | 67.87M | 49.01M | 43.63M | 32.86M |
| EPS (Basic) | -1.58 | -1.41 | -1.60 | -2.40 | -2.61 | -2.62 |
| EPS (Diluted) | -1.58 | -1.41 | -1.60 | -2.40 | -2.61 | -2.62 |
| Free Cash Flow | -93.90M | -89.91M | -104.11M | -114.31M | -104.11M | -72.95M |
| Free Cash Flow Per Share | -1.26 | -1.22 | -1.53 | -2.33 | -2.39 | -2.22 |
| EBITDA | -113.44M | -106.64M | -119.04M | -120.48M | -116.32M | -84.67M |
| D&A For EBITDA | 9.63M | 9.19M | 9.15M | 5.87M | 2.64M | 1.76M |
| EBIT | -123.08M | -115.84M | -128.19M | -126.35M | -118.95M | -86.43M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 24.96M | 39.63M | 27.87M | 31.04M | 37.49M | 60.82M |
| Short-Term Investments | 157.81M | 236.65M | 239.48M | 217.15M | 314.65M | 177.27M |
| Cash & Short-Term Investments | 182.76M | 276.28M | 267.35M | 248.19M | 352.14M | 238.09M |
| Receivables | 2.10M | |||||
| Prepaid Expenses | 3.18M | 3.82M | 3.25M | 3.26M | 5.62M | 4.54M |
| Other Current Assets | 2.41M | 2.73M | 1.62M | 2.93M | 3.15M | |
| Total Current Assets | 188.04M | 282.51M | 273.34M | 253.07M | 360.69M | 245.78M |
| Property, Plant & Equipment | 87.71M | 101.15M | 110.67M | 119.28M | 107.66M | 24.53M |
| Long-Term Investments | 57.67M | 16.11M | 110.39M | |||
| Other Long-Term Assets | 4.22M | 4.44M | 6.80M | 6.54M | 4.59M | 3.59M |
| Total Assets | 337.64M | 404.21M | 501.20M | 378.88M | 472.94M | 273.90M |
| Accounts Payable | 3.82M | 2.09M | 638.00K | 3.67M | 1.76M | 1.11M |
| Accrued Expenses | 12.46M | 13.29M | 11.97M | 13.42M | 11.04M | 9.25M |
| Current Portion of Leases | 7.28M | 6.89M | 6.05M | 6.07M | 4.25M | 2.48M |
| Other Current Liabilities | 254.00K | 174.00K | 5.00M | 96.00K | ||
| Total Current Liabilities | 23.56M | 22.27M | 18.92M | 23.33M | 22.05M | 12.94M |
| Long-Term Leases | 66.26M | 69.53M | 74.22M | 82.27M | 78.69M | 9.97M |
| Other Long-Term Liabilities | 87.00K | 87.00K | 87.00K | 18.00K | ||
| Total Liabilities | 89.91M | 91.88M | 93.23M | 105.60M | 100.73M | 22.94M |
| Common Stock | 7.00K | 7.00K | 7.00K | 5.00K | 5.00K | 3.00K |
| Additional Paid-In Capital | 964.66M | 960.22M | 951.52M | 708.71M | 690.81M | 455.21M |
| Retained Earnings | -716.51M | -648.31M | -544.22M | -435.43M | -317.93M | -204.10M |
| Comprehensive Income & Other | -425.00K | 407.00K | 674.00K | 8.00K | -679.00K | -150.00K |
| Total Common Equity | 247.74M | 312.32M | 407.98M | 273.29M | 372.21M | 250.97M |
| Shareholders' Equity | 247.74M | 312.32M | 407.98M | 273.29M | 372.21M | 250.97M |
| Total Liabilities & Equity | 337.64M | 404.21M | 501.20M | 378.88M | 472.94M | 273.90M |
| Total Debt | 73.54M | 76.42M | 80.27M | 88.34M | 82.93M | 12.46M |
| Net Cash (Debt) | 109.22M | 199.86M | 187.08M | 159.85M | 269.21M | 225.63M |
| Net Cash Per Share | 1.47 | 2.70 | 2.76 | 3.26 | 6.17 | 6.87 |
| Filing Date Shares Outstanding | 71.62M | 71.29M | 70.96M | 49.42M | 48.93M | 33.00M |
| Total Common Shares Outstanding | 71.62M | 71.08M | 70.65M | 49.18M | 48.88M | 32.97M |
| Working Capital | 164.48M | 260.25M | 254.42M | 229.74M | 338.64M | 232.84M |
| Book Value Per Share | 3.46 | 4.39 | 5.78 | 5.56 | 7.62 | 7.61 |
| Tangible Book Value | 247.74M | 312.32M | 407.98M | 273.29M | 372.21M | 250.97M |
| Tangible Book Value Per Share | 3.46 | 4.39 | 5.78 | 5.56 | 7.62 | 7.61 |
| Machinery | 20.85M | 18.62M | 18.06M | 15.45M | 13.68M | 10.31M |
| Construction In Progress | 2.52M | 10.57M | 10.82M | 8.95M | 49.66M | 2.27M |
| Leasehold Improvements | 69.53M | 66.49M | 66.62M | 66.62M | 4.40M | 3.46M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -117.32M | -104.08M | -108.79M | -117.50M | -113.84M | -86.08M |
| Depreciation & Amortization | 9.63M | 9.19M | 9.15M | 5.87M | 2.64M | 1.76M |
| Asset Writedown & Restructuring Costs | 8.84M | 791.00K | 4.10M | |||
| Loss (Gain) From Sale of Investments | -3.08M | -4.67M | -6.91M | -8.97M | -328.00K | 3.24M |
| Stock-Based Compensation | 7.43M | 8.56M | 16.73M | 17.20M | 16.86M | 14.46M |
| Other Operating Activities | 2.12M | 1.95M | 2.29M | 2.22M | 3.94M | 337.00K |
| Change in Accounts Payable | 3.69M | 2.46M | -4.47M | 4.22M | 2.76M | 2.79M |
| Change in Other Net Operating Assets | -4.06M | -2.90M | -7.69M | 6.70M | 30.98M | -4.43M |
| Operating Cash Flow | -92.76M | -88.70M | -99.70M | -86.16M | -57.00M | -67.93M |
| Capital Expenditures | -1.15M | -1.21M | -4.41M | -28.15M | -47.11M | -5.03M |
| Investment in Securities | 64.70M | 101.53M | -125.15M | 107.16M | -137.58M | 37.56M |
| Investing Cash Flow | 63.55M | 100.32M | -129.56M | 79.02M | -184.69M | 32.53M |
| Issuance of Common Stock | 746.00K | 141.00K | 226.08M | 691.00K | 219.01M | 1.48M |
| Other Financing Activities | -277.00K | |||||
| Financing Cash Flow | 746.00K | 141.00K | 226.08M | 691.00K | 219.01M | 1.20M |
| Net Cash Flow | -28.46M | 11.76M | -3.17M | -6.45M | -22.68M | -34.19M |
| Free Cash Flow | -93.90M | -89.91M | -104.11M | -114.31M | -104.11M | -72.95M |
| Free Cash Flow Per Share | -1.26 | -1.22 | -1.53 | -2.33 | -2.39 | -2.22 |
| Levered Free Cash Flow | -55.13M | -53.59M | -64.14M | -80.92M | -95.48M | -43.57M |
| Unlevered Free Cash Flow | -55.13M | -53.59M | -64.14M | -80.92M | -95.48M | -43.57M |
| Change in Working Capital | -379.00K | -435.00K | -12.16M | 10.93M | 33.74M | -1.64M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 109.94M | 131.40M | 175.72M | 323.88M | 292.39M | 505.77M |
| Enterprise Value | 719.05K | -74.29M | -21.89M | 137.73M | -16.49M | 260.89M |
| Last Close Price | 1.56 | 1.85 | 2.49 | 6.60 | 5.99 | 15.35 |
| PB Ratio | 0.45 | 0.42 | 0.43 | 1.19 | 0.79 | 2.02 |
| P/TBV Ratio | 0.45 | 0.42 | 0.43 | 1.19 | 0.79 | 2.02 |
| Debt / Equity Ratio | 0.30 | 0.24 | 0.20 | 0.32 | 0.22 | 0.05 |
| Net Debt / Equity Ratio | -0.44 | -0.64 | -0.46 | -0.58 | -0.72 | -0.90 |
| Net Debt / EBITDA Ratio | 0.96 | 1.87 | 1.57 | 1.33 | 2.31 | 2.67 |
| Net Debt / FCF Ratio | 1.16 | 2.22 | 1.80 | 1.40 | 2.59 | 3.09 |
| Quick Ratio | 7.85 | 12.41 | 14.13 | 10.64 | 15.97 | 18.39 |
| Current Ratio | 7.98 | 12.69 | 14.45 | 10.85 | 16.36 | 18.99 |
| Return on Equity (ROE) | -38.76% | -28.90% | -31.94% | -36.41% | -36.53% | -30.09% |
| Return on Assets (ROA) | -19.57% | -15.99% | -18.21% | -18.54% | -19.91% | -17.67% |
| Return on Capital Employed (ROCE) | -39.20% | -30.30% | -26.60% | -35.50% | -26.40% | -33.10% |
| Earnings Yield | -103.00% | -79.21% | -61.91% | -36.28% | -38.93% | -17.02% |
| FCF Yield | -84.04% | -68.42% | -59.25% | -35.29% | -35.61% | -14.42% |
| Buyback Yield / Dilution | -0.56% | -9.03% | -38.46% | -12.34% | -32.79% | -95.50% |